Wesfarmers Ltd (ASX: WES) has landed itself in a spot of bother lately, and its share price has taken a tumble.

Source: Google Finance

Source: Google Finance

As shown above, the Wesfarmers share price is down 6% in the last four days. That compares to a 0.61% increase in the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO).

No doubt, some shareholders will be left wondering if now is a good time to sell out.

Is Wesfarmers Ltd a sell?

Following the announcement of impairment charges (mostly due to goodwill for the Target business), amounting to as much as $2.3 billion, announced earlier in the week, a number of prominent analysts have moved to downgrade their intrinsic value estimates of Wesfarmers’ shares.

According to Dow Jones Newswires, Morgan Stanley and Macquarie analysts cut their price targets to $39 and $42.61, respectively. Wesfarmers last traded at $40.40.

What does that mean?

It’s easy to see media headlines declaring ‘$2.3 billion in impairment charges’ and Wesfarmers’ subsequent share price falls as a cause for concern.

However, taking the time to understand the company’s announcement is vital to making a prudent investment decision. Indeed, as can be seen from the modest analyst downgrades, the charges to be incurred aren’t as meaningful as the financial media would have you believe.

Foolish takeaway

Goodwill is an accounting item which arises from acquisitions. Basically, it is the difference between the purchase price of an acquisition and its assets.

Wesfarmers’ decision to write-down or impair the goodwill associated with its Target business was a long time in the making. While — retrospectively — we can say Target was a terrible investment, Wesfarmers also bought Coles, a business which has more than earned its stripes under the Wesfarmers banner. Meanwhile, the Curragh business is in a very tough industry, so its write-downs should not have caught analysts by surprise.

In my opinion, the decision to incur these charges does not make Wesfarmers a sell, nor does the recent share price drop make it a buy.

I'm not a buyer of Wesfarmers shares today because I'm looking for other - faster growing - dividend shares to add to my portfolio, like the one The Motley Fool's expert analysts hand-picked as their best dividend share idea for 2016.

Indeed, our resident dividend experts named their Top Dividend Share for 2016. Not only are the shares dirt cheap, the company is growing and trading on a 5.6% fully franked dividend yield. Simply click here to gain access to this comprehensive FREE investment report, including the name of this fast growing ASX dividend share. No credit card required!

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned in this article. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @ASXinvest.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.